IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Preclinical biotech developing immune therapies for cancer.
Industry: Health Care
Latest Trade: $6.75 0.00 (0.0%)
First Day Return: +0.6%
Return from IPO: -57.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/08/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/29/2021 |
Offer Price | $16.00 |
Price Range $15.00 - $17.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $120 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Jefferies |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2017 |
Employees | 29 |
Website werewolftx.com |